Enlivex Ltd.
corporate_fare Company Profile
Enlivex Ltd. (NASDAQ:ENLV) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 34 items for ENLV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-02, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 19 rated 8 or above. Recent SEC coverage for ENLV spans 6-K/A, 6-K, F-3.
Recent high-impact activity:
- Enlivex Seeks Shareholder Approval for New 1-for-13 to 1-for-16 Reverse Split and Up to 1-for-1,000 Additional Splits to Avoid Nasdaq Delisting
- Enlivex Sets October 14 Vote on 1-for-16 Reverse Split to Regain Nasdaq Compliance
- Enlivex Reports $1.95B H1 Net Income on $2.55B Non-Cash Digital Asset Gains
- Enlivex Terminates $400M Rain Foundation Private Placement
- Enlivex Amends Lind Note: Principal Jumps to $19.2M, Conversion Price Set at 80% of Market with $1.50 Floor Reserve
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 48,204 shares in ENLV as of the September 15, 2026 settlement, a 59.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 16.2% of ENLV volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for ENLV, detected from its recent SEC filings · based on capital-structure filings through 2026-08-15.
Additional Share Registration · Conversion Price Far Above Market
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
ENLV files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.